SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

WNX Wellnex Life Limited

Consumer Defensive · Packaged Foods · website
$0.08
52wk 0.04 – 0.25
Overall
33.9
Value
100.0
Growth
0.0
Health
26.9
Quality
0.0
Momentum
34.5
Dividend
—
Price
About Wellnex Life Limited

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia and New Zealand. It offers topical anti-inflammatory creams, sprays, and roll-ons for the relief of joint and muscle pain under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. The company is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities, as well as sales and distribution activities. It exports its products to the United Kingdom and the United Arab Emirates. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.

Price analytics

Returns

1 day 0.0%
1 week -6.2%
1 month -12.6%
3 months 38.2%
6 months 1.3%
1 year -66.2%
3 years -96.2%

Risk

Volatility (1y ann.) 147.5%
Beta vs ASX 200 0.08
Sharpe (1y) -0.20
VaR 95% (1-day) -9.1%
Max drawdown (1y) -82.8%
Off 1-year high -69.6%

Technicals

RSI(14) 31
vs 50DMA -3.1%
vs 200DMA -9.4%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 100.0
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
100
Growth 0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 26.9
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
39
Debt / Equity
39
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 34.5
6-month return vs ASX 200
60
Price vs 200-day average
19
Price vs 50-day average
35
Position in 52-week range
16

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$5.55M
P/E (trailing)
—
P/E (forward)
1.52
EPS (trailing)
-0.14
Dividend yield
—
Payout ratio
0.0%
Beta
1.32
EV / EBITDA
-33.58
Price / Book
0.75
ROE
-48.6%
Operating margin
-9.2%
Net margin
-18.3%
Total cash
$862,000
Total debt
$9.68M
Current ratio
1.46
Debt / Equity
1.30
Free cash flow
$-19.56M
Avg volume
68,227
Latest annual results (FY ending 30 Jun 2024)
  • Revenue$16.93M
  • Gross profit$5.07M
  • Operating income-$6.45M
  • Net income-$14.74M
  • Diluted EPS-0.78
  • Free cash flow-$6.87M
  • Net debt$9.76M
Sector peers (Consumer Defensive)
TickerMkt cap P/EScore
WOW $46.85B 41.7 35.9
COL $30.95B 28.4 42.5
EDV $5.35B 99.3 24.2
A2M $4.86B 29.0 48.3
TWE $4.54B — 51.6
MTS $3.18B 11.6 48.9
BGA $1.92B 34.8 44.4
GNC $1.43B — 35.9